EMEA-001460-PIP01-13-M02
Key facts
Invented name |
Genvoya
|
Active substance |
|
Therapeutic area |
Infectious diseases
|
Decision number |
P/0211/2017
|
PIP number |
EMEA-001460-PIP01-13-M02
|
Pharmaceutical form(s) |
Film-coated tablet
|
Condition(s) / indication(s) |
Treatment of human immunodeficiency virus (HIV-1) infection
|
Route(s) of administration |
Oral use
|
Contact for public enquiries |
Gilead Sciences International Ltd
|
Decision type |
PM: decision on the application for modification of an agreed PIP
|